Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Endocrinology · Classic Salt-Wasting Congenital Adrenal Hyperplasia

Understanding the Diagnosis: Biology and Lab Results

At a Glance

Classic salt-wasting CAH is diagnosed when newborn screening shows high 17-OHP levels due to a missing 21-hydroxylase enzyme. Doctors confirm the diagnosis using advanced blood tests, electrolyte checks for dangerous salt loss, and genetic testing.

Understanding how doctors diagnosed your child with Classic Salt-Wasting Congenital Adrenal Hyperplasia (SW CAH) requires looking inside the body’s chemical “factory.” This condition is not caused by an illness or infection; it is a biological “assembly line” failure caused by a change in the CYP21A2 gene [1][2].

The Adrenal Factory Analogy

Think of your baby’s adrenal glands as a factory that takes raw materials and turns them into three different “products” (hormones): cortisol, aldosterone, and androgens.

In a child with SW CAH, the factory is missing a critical worker—the 21-hydroxylase enzyme [1][3].

  • The Logjam: Because the 21-hydroxylase worker is missing, the assembly line stops midway. A raw material called 17-hydroxyprogesterone (17-OHP) begins to pile up in the factory because it can’t be turned into the final products [4][5].
  • The Shortage: The factory cannot produce cortisol (the stress hormone) or aldosterone (the salt-saving hormone) [1].
  • The Overflow: To clear the logjam, the factory shunts all those extra raw materials (17-OHP) down a different side-conveyor belt. This belt produces androgens (male-type hormones like testosterone) [4][6].
  • The Feedback Loop: The brain senses there is no cortisol, so it sends a loud “alarm” hormone called ACTH to tell the factory to work harder. This makes the adrenal glands grow larger (hyperplasia), which only creates more androgens and more 17-OHP buildup [4][7].

How the Diagnosis is Confirmed

Most cases are first caught by newborn screening, where a small drop of blood is taken from your baby’s heel shortly after birth [8].

  1. Initial Screen (17-OHP): The lab looks for high levels of 17-OHP. Because 17-OHP can naturally be high in premature or stressed babies, this test sometimes gives a “false positive” [9][10].
  2. Second-Tier Test (LC-MS/MS): If the first screen is high, a more precise test called Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is used. This sophisticated tool can measure several hormones at once (like 21-deoxycortisol) to confirm the diagnosis with much higher accuracy [11][12].
  3. Electrolyte Check: Doctors look for signs of “salt-wasting” in the blood. The two main red flags are hyponatremia (dangerously low sodium/salt) and hyperkalemia (dangerously high potassium) [13][14].
  4. Renin Test: They may also measure plasma renin activity. Renin is a hormone that rises when the body is desperately trying to hold onto salt [15].
  5. Genetic Testing: Finally, a blood test can look directly at the CYP21A2 gene to identify the specific mutation, which helps confirm the diagnosis and predicts how severe the salt-wasting might be [16][17].

Recognizing a Salt-Wasting Crisis

A “crisis” occurs when the body’s lack of salt and cortisol becomes life-threatening. Newborn screening aims to find babies before this happens, but it is vital to know the early signs [18][19]:

  • Poor feeding: The baby is too tired to suck or loses interest in milk [13].
  • Vomiting: This is a major warning sign as it causes further salt loss [13][5].
  • Dehydration: Fewer wet diapers or a sunken soft spot (fontanelle) on the head [13].
  • Lethargy: The baby is unusually sleepy and difficult to wake up [13].

Diagnostic Checklist

Your medical team will likely use this combination of tests to be 100% certain:

  • 17-OHP (17-hydroxyprogesterone): To check for the assembly line logjam [5].
  • Electrolytes (Sodium/Potassium): To check for salt-wasting [13].
  • Plasma Renin: To see if the body is starved for salt [15].
  • Genetic Testing (CYP21A2): To find the underlying DNA cause [16].
  • Karyotype: A test to confirm the baby’s biological sex (XX or XY chromosomes), especially if the external genitals look ambiguous [20].

Return to Home Page

Common questions in this guide

What does a high 17-OHP level on a newborn screening mean?
A high 17-OHP level indicates that the adrenal glands are missing a specific enzyme, causing raw materials to build up instead of turning into cortisol. Because premature or stressed babies can also have high levels, a more precise second test is needed to confirm the diagnosis.
How do doctors confirm a salt-wasting CAH diagnosis?
Doctors confirm the diagnosis using advanced blood tests like LC-MS/MS to measure specific hormones accurately. They also check electrolyte levels for low sodium and high potassium, measure plasma renin, and perform genetic testing to find the exact cause.
What are the early warning signs of a salt-wasting crisis in a baby?
Early warning signs include poor feeding, severe vomiting, extreme sleepiness, and signs of dehydration like fewer wet diapers or a sunken soft spot on the head. A salt-wasting crisis is a medical emergency that requires immediate care.
Why do doctors test the CYP21A2 gene?
Changes or mutations in the CYP21A2 gene are the underlying biological cause of 21-hydroxylase deficiency. Genetic testing identifies the specific mutation, helping doctors predict the severity of the salt-wasting and tailor your baby's treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.My baby's 17-OHP was high, but what was the result of the second-tier LC-MS/MS test (like 21-deoxycortisol)?
  2. 2.Are my baby's potassium and sodium levels currently in the safe range, or do we need to give IV fluids?
  3. 3.Does my baby's specific CYP21A2 gene mutation predict a complete loss of the 21-hydroxylase enzyme?
  4. 4.How high was the ACTH level, and does that help confirm how hard the adrenal glands are working overtime?
  5. 5.When should we repeat the 'renin' test to make sure the fludrocortisone dose is correct for the salt-wasting?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort.

    Liu Y, Zheng J, Liu N, et al.

    Molecular genetics & genomic medicine 2020; (8(11)):e1501 doi:10.1002/mgg3.1501.

    PMID: 32959514
  2. 2

    Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self-management.

    Ekbom K, Strandqvist A, Lajic S, et al.

    Clinical endocrinology 2021; (94(5)):753-764 doi:10.1111/cen.14398.

    PMID: 33346381
  3. 3

    Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.

    Parsa AA, New MI

    The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):2-11 doi:10.1016/j.jsbmb.2016.06.015.

    PMID: 27380651
  4. 4

    MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis.

    Miller WL

    European journal of endocrinology 2018; (179(3)):R125-R141.

    PMID: 29880708
  5. 5

    Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate.

    Manzoor N, Minhaj A, Akmal M

    Cureus 2019; (11(5)):e4749 doi:10.7759/cureus.4749.

    PMID: 31363431
  6. 6

    Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment.

    Loli P, Menotti S, di Filippo L, Giustina A

    Endocrine 2025; (90(1)):1-16 doi:10.1007/s12020-025-04341-5.

    PMID: 40699527
  7. 7

    Management challenges and therapeutic advances in congenital adrenal hyperplasia.

    Mallappa A, Merke DP

    Nature reviews. Endocrinology 2022; (18(6)):337-352 doi:10.1038/s41574-022-00655-w.

    PMID: 35411073
  8. 8

    Neonatal Screening and Genotype-Phenotype Correlation of 21-Hydroxylase Deficiency in the Chinese Population.

    Wang X, Wang Y, Ma D, et al.

    Frontiers in genetics 2020; (11()):623125 doi:10.3389/fgene.2020.623125.

    PMID: 33552137
  9. 9

    Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.

    Hayashi GY, Carvalho DF, de Miranda MC, et al.

    Clinical endocrinology 2017; (86(4)):480-487 doi:10.1111/cen.13292.

    PMID: 27978607
  10. 10

    Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.

    de Hora MR, Heather NL, Webster D, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(9)):e3390-e3399 doi:10.1210/clinem/dgab383.

    PMID: 34058748
  11. 11

    Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.

    Zhan X, Han L, Qiu W, et al.

    Steroids 2022; (185()):109056 doi:10.1016/j.steroids.2022.109056.

    PMID: 35660382
  12. 12

    Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand.

    de Hora MR, Heather NL, Patel T, et al.

    International journal of neonatal screening 2020; (6(1)):6.

    PMID: 33073005
  13. 13

    A Novel Steroidogenic Acute Regulatory Protein (StAR) Mutation Causing Adrenal Insufficiency in a Neonate: A Case Report of a Rare Medical Condition.

    Rawat A, Karotkar S, Lakra M, et al.

    Cureus 2024; (16(8)):e66080 doi:10.7759/cureus.66080.

    PMID: 39229408
  14. 14

    The presentation of congenital adrenal hyperplasia in an unscreened population.

    Conlon TA, Hawkes CP, Brady JJ, Murphy NP

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(9)):1123-1129 doi:10.1515/jpem-2021-0123.

    PMID: 34167176
  15. 15

    Mineralocorticoid replacement therapy in salt-wasting congenital adrenal hyperplasia.

    Lang K, Quinkler M, Kienitz T

    Clinical endocrinology 2024; (101(4)):346-358 doi:10.1111/cen.14959.

    PMID: 37564007
  16. 16

    Molecular Analysis of 21-Hydroxylase Deficiency Reveals Two Novel Severe Genotypes in Affected Newborns.

    Concolino P, Paragliola RM

    Molecular diagnosis & therapy 2021; (25(3)):327-337 doi:10.1007/s40291-021-00520-y.

    PMID: 33710594
  17. 17

    In Silico Structural and Biochemical Functional Analysis of a Novel CYP21A2 Pathogenic Variant.

    Cohen M, Pignatti E, Dines M, et al.

    International journal of molecular sciences 2020; (21(16)) doi:10.3390/ijms21165857.

    PMID: 32824094
  18. 18

    The progression of salt-wasting and the body weight change during the first 2 weeks of life in classical 21-hydroxylase deficiency patients.

    Gau M, Konishi K, Takasawa K, et al.

    Clinical endocrinology 2021; (94(2)):229-236 doi:10.1111/cen.14347.

    PMID: 33001476
  19. 19

    Improved Performance of Newborn Screening for Congenital Adrenal Hyperplasia Using 21-deoxycortisol Measurement.

    Lawrence SE, Marcadier J, Auger S, et al.

    Journal of the Endocrine Society 2026; (10(1)):bvaf157 doi:10.1210/jendso/bvaf157.

    PMID: 41394115
  20. 20

    Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns

    Yavaş Abalı Z, Kurnaz E, Güran T

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):33-43 doi:10.4274/jcrpe.galenos.2024.2024-6-10-S.

    PMID: 39713885

This page explains diagnostic tests and biology for salt-wasting CAH for educational purposes only. Always consult a pediatric endocrinologist or your child's medical team for interpreting specific lab results and guiding care.

Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.